Compassionate Use
Early Access Program: Access to innovative medicines for patients
A pharmaceutical company with a focus on clinical research has implemented a compassionate use program at the request of the medical profession.
Experimental therapy
Swiss doctors have enquired with an international pharmaceutical company about the availability of a drug not approved in Switzerland for the treatment of a fatal disease as part of an experimental trial.